Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff

• Status: Recruiting
• Trial end date: 2020-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators plan to carry out an experimental study on the preventive effect of recombinant human interferon alpha nasal drops on the infection of 2019 new coronavirus in medical staff.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Shanghai Jiao Tong University School of Medicine
• Treatments: Interferon-alfa-1b; Interferon-alpha; Interferons; Thymalfasin

Criteria

Inclusion Criteria:

• Formally serving medical staff in Taihe Hospital;

Exclusion Criteria:

• pregnant women;

• severe chronic diseases who are unable to participate in daily routine work;

• fever (temperature≥37.3 ° ) and / or respiratory symptoms.